Posters
« Back
Anesthetic Considerations for Parkinson
EP27443
Poster Title: Anesthetic Considerations for Parkinson's Disease
Submitted on 15 Apr 2018
Author(s): Jeremy Hoa Bui
Affiliations: Nova Southeastern University
This poster was presented at AAAA 2018
Poster Views: 636
View poster »


Poster Information
Abstract: Parkinson disease, a neurodegenerative disease, is commonly increased in elderly people and becoming a big challenge for anesthesia. There are approximately 60,000 American people diagnosed with PD each year1. The majority of people have diseases at the age of 50 years or later. Parkinson Disease (PD) is a type of neurodegenerative disorder of the loss of dopaminergic neurons in subtantia nigra. It has been the hallmark of Parkinson’s disease for over 300 years and yet there are no causes and cures found. However, there are many etiologic factors, such as: organophosphate exposure, dietary factors, and lifestyle factors. The epidemiology is associated with increased aging, tremendously decreasing motor neurons; therefore, it causes rigidity, resting tremor, and involuntary movement. Ecstasy is also known for the disruption of the transportation for neurotransmitter such as dopamine and serotonin. In fact, there are many clinical manifestations to optimize the neurological conditions and physiological changes in the preoperative, intraoperative, and postoperative parameter. Particularly, the considerations of pharmacological agents are administered in anesthesia management in stereotactic pallidotomy and deep brain stimulation. The brief review is the consolidation of knowledge and skills for anesthesia care of patients with Parkinson’s disease.
Summary: PD patients require unique anesthetic management which decrease morbidity, mortality perioperatively and complications postoperatively.
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Distinct deposition of amyloid-bspecies in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry
Nobuto Kakuda1, Tomohiro Miyasaka1, Takashi Nirasawa2, Shigeo Murayama3, Yasuo Ihara1 and Masaya Ikegawa1

Improved Expansion of Neural Stem Cells with Gibco™ Heat Stable Recombinant Human Basic Fibroblast Growth Factor
Brittany Balhouse, Diana Navarro, Richard Josephson, and Matthew Dallas

Endocrine Disruptors and Impact of Nutritional Intervention on Hypothyroid Women - A Study in Kolkata
Swapan Banerjee

Strategies for High-Titer Protein Expression Using the ExpiCHO and Expi293 Transient Expression Systems
Chao Yan Liu, Jian Liu, Wanhua Yan, Kyle Williston, Katy Irvin, Henry Chou, Jonathan Zmuda

A Chemically-Defined Baculovirus-Based Expression System for Enhanced Protein Production in Sf9 Cells
Maya Yovcheva, Sara Barnes, Kenneth Thompson, Melissa Cross, Katy Irvin, Mintu Desai, Natasha Lucki, Henry Chiou, Jonathan Zmuda